156 related articles for article (PubMed ID: 18850120)
21. Increased risk of human parvovirus B19 infection in day-care employees: a cohort study among pregnant workers during an epidemic in Finland.
Riipinen A; Sallmén M; Hedman L; Ojajärvi A; Lindbohm ML; Meriluoto M; Surcel HM; Taskinen H; Nuutila M; Karikoski R; Hedman K; Söderlund-Venermo M
Occup Environ Med; 2014 Dec; 71(12):836-41. PubMed ID: 25074899
[TBL] [Abstract][Full Text] [Related]
22. Low seroprevalence of parvovirus B19 in Taiwanese children and young adults.
Su WJ; Ni YH; Liu DP; Chiou LS; Cheng WY; Wu JS; Lu CY
Pediatr Neonatol; 2010 Oct; 51(5):265-8. PubMed ID: 20951355
[TBL] [Abstract][Full Text] [Related]
23. Renal anemia aggravated by long-term parvovirus B19 and cytomegalovirus infection in a renal transplant patient: case report and evaluation of B19 seroprevalence in dialysis patients.
Becker MR; Schneider B; Reber U; Pöge U; Klein B; Klehr HU; Zhou H; Fischer HP; Eis-Hübinger AM
Transplant Proc; 2005 Dec; 37(10):4306-8. PubMed ID: 16387104
[TBL] [Abstract][Full Text] [Related]
24. Serosurvey of parvovirus B19 and cytomegalovirus infections among female university students in Shiraz, Southern Iran.
Joharinia N; Salehnasab P; Shirvani M; Shahriari B; Savardashtaki A; Sarvari J
J Immunoassay Immunochem; 2021 Mar; 42(2):202-209. PubMed ID: 33428512
[TBL] [Abstract][Full Text] [Related]
25. Seroepidemiology of cytomegalovirus infections in Croatia.
Vilibic-Cavlek T; Kolaric B; Beader N; Vrtar I; Tabain I; Mlinaric-Galinovic G
Wien Klin Wochenschr; 2017 Feb; 129(3-4):129-135. PubMed ID: 27599701
[TBL] [Abstract][Full Text] [Related]
26. Correlates of placental infection with cytomegalovirus, parvovirus B19 or human herpes virus 7.
Chow SS; Craig ME; Jacques CF; Hall B; Catteau J; Munro SC; Scott GM; Camaris C; McIver CJ; Rawlinson WD
J Med Virol; 2006 Jun; 78(6):747-56. PubMed ID: 16628574
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for cytomegalovirus seropositivity in a population of day care educators in Montréal, Canada.
Joseph SA; Beliveau C; Muecke CJ; Rahme E; Soto JC; Flowerdew G; Johnston L; Langille D; Gyorkos TW
Occup Med (Lond); 2005 Oct; 55(7):564-7. PubMed ID: 16251375
[TBL] [Abstract][Full Text] [Related]
28. [Antibodies against human parvovirus B19 in the Madrid community].
de Ory F; Pachón I; Ramírez R; Echevarría JM
Enferm Infecc Microbiol Clin; 1999; 17(7):364-5. PubMed ID: 10535193
[No Abstract] [Full Text] [Related]
29. Cytomegalovirus infection in day care centers in Rome, Italy: viral excretion in children and occupational risk among workers.
Volpi A; Pica F; Cauletti M; Panà A; Rocchi G
J Med Virol; 1988 Oct; 26(2):119-25. PubMed ID: 2846774
[TBL] [Abstract][Full Text] [Related]
30. The association of pityriasis rosea with cytomegalovirus, Epstein-Barr virus and parvovirus B19 infections - a prospective case control study by polymerase chain reaction and serology.
Chuh AA
Eur J Dermatol; 2003; 13(1):25-8. PubMed ID: 12609777
[TBL] [Abstract][Full Text] [Related]
31. Cytomegalovirus seroprevalence among solid organ donors in Hungary: correlations with age, gender, and blood group.
Varga M; Görög D; Kári D; Környei E; Kis É; Túryné HJ; Jankovics I; Péter A; Toronyi É; Sárváry E; Fazakas J; Reusz G
Transplant Proc; 2011 May; 43(4):1233-5. PubMed ID: 21620098
[TBL] [Abstract][Full Text] [Related]
32. [Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey].
Ataman S; Colak D; Günseren F; Senol Y; Colak T; Aktekin MR; Gültekin M
Mikrobiyol Bul; 2007 Oct; 41(4):545-55. PubMed ID: 18173073
[TBL] [Abstract][Full Text] [Related]
33. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria.
Abiodun I; Opaleye OO; Ojurongbe O; Fagbami AH
J Infect Dev Ctries; 2013 Dec; 7(12):946-50. PubMed ID: 24334941
[TBL] [Abstract][Full Text] [Related]
34. [Seroprevalence of parvovirus B19 in patients with chronic idiopathic thrombocytopenic purpura].
Uslu H; Kiki I; Ozbek A; Erdem F; Ayyildiz A
Mikrobiyol Bul; 2007 Oct; 41(4):597-602. PubMed ID: 18173080
[TBL] [Abstract][Full Text] [Related]
35. Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study.
Varache S; Narbonne V; Jousse-Joulin S; Guennoc X; Dougados M; Daurès JP; Devauchelle-Pensec V; Saraux A
Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1565-70. PubMed ID: 21954118
[TBL] [Abstract][Full Text] [Related]
36. Frequent occurrence of parvovirus B19 DNAemia in the first year after kidney transplantation.
Porignaux R; Vuiblet V; Barbe C; Nguyen Y; Lavaud S; Toupance O; Andréoletti L; Rieu P; Lévêque N
J Med Virol; 2013 Jun; 85(6):1115-21. PubMed ID: 23588740
[TBL] [Abstract][Full Text] [Related]
37. The burden of parvovirus B19 infection in women of childbearing age in England and Wales.
Vyse AJ; Andrews NJ; Hesketh LM; Pebody R
Epidemiol Infect; 2007 Nov; 135(8):1354-62. PubMed ID: 17291377
[TBL] [Abstract][Full Text] [Related]
38. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.
Rezaei F; Sarshari B; Ghavami N; Meysami P; Shadab A; Salimi H; Mokhtari-Azad T
J Med Virol; 2016 Jun; 88(6):947-53. PubMed ID: 26538067
[TBL] [Abstract][Full Text] [Related]
40. A population-based epidemiological survey of human parvovirus B19 infection: a project of the Kyushu and Okinawa Population Study (KOPS).
Ihara T; Furusyo N; Hayashi T; Toyoda K; Murata M; Hayashi J
Arch Virol; 2013 Dec; 158(12):2465-72. PubMed ID: 23775357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
